{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:26:18Z","timestamp":1792113978637,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bja.2021.11.016","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T17:18:25Z","timestamp":1639415905000},"page":"759-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Management of new onset atrial fibrillation in critically unwell adult patients: a systematic review and narrative synthesis"],"prefix":"10.1016","volume":"128","author":[{"given":"Brian W.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung S.","family":"Chean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruaraidh","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronagh","family":"Blackwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny F.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg D.","family":"Welters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2021.11.016_bib1","first-page":"9","article-title":"Epidemiology, prevention, and treatment of new-onset atrial fibrillation in critically ill: a systematic review","volume":"3","author":"Yoshida","year":"2015","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.bja.2021.11.016_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1164\/rccm.201603-0618OC","article-title":"Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis a cohort study","volume":"195","author":"Klein Klouwenberg","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib3","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc9057","article-title":"Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study","volume":"14","author":"Meierhenrich","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.bja.2021.11.016_bib4","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1097\/CCM.0000000000001166","article-title":"Atrial fibrillation is an independent predictor of mortality in critically ill patients HHS Public Access","volume":"43","author":"Shaver","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1378\/chest.14-0003","article-title":"Long-term outcomes following development of new-onset atrial fibrillation during sepsis","volume":"146","author":"Walkey","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.bja.2021.11.016_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/00015385.2018.1477035","article-title":"New-onset atrial fibrillation is associated with increased mortality in critically ill patients: a systematic review and meta-analysis","volume":"74","author":"Kanjanahattakij","year":"2019","journal-title":"Acta Cardiol"},{"key":"#cr-split#-10.1016\/j.bja.2021.11.016_bib7.1","unstructured":"Atrial fibrillation: management. Guidance and guidelines. NICE. [cited 2018 Oct 17]"},{"key":"#cr-split#-10.1016\/j.bja.2021.11.016_bib7.2","unstructured":"Available from: https:\/\/www.nice.org.uk\/guidance\/cg180. [Accessed 2021 Feb 17]"},{"key":"10.1016\/j.bja.2021.11.016_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bja.2021.11.016_bib9","series-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","author":"January","year":"2019"},{"key":"10.1016\/j.bja.2021.11.016_bib10","series-title":"Atrial fibrillation \u2013 diagnosis and management","year":"2015"},{"key":"10.1016\/j.bja.2021.11.016_bib11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.chest.2018.03.040","article-title":"Atrial fibrillation in the ICU","volume":"154","author":"Bosch","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.bja.2021.11.016_bib12","first-page":"2248","article-title":"Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis","volume":"23","author":"Walkey","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2021.11.016_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1440-1681.2009.05303.x","article-title":"The hypotensive effect of intravenous amiodarone is sustained throughout the maintenance infusion period","volume":"37","author":"Cushing","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bja.2021.11.016_bib14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","article-title":"Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias","volume":"29","author":"Delle Karth","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc4975","article-title":"Coagulation abnormalities in critically ill patients","volume":"10","author":"Levi","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.bja.2021.11.016_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1378\/chest.15-0358","article-title":"Optimizing atrial fibrillation management","volume":"148","author":"Walkey","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.bja.2021.11.016_bib17","article-title":"A\u00a0systematic review of anticoagulation strategies for patients with atrial fibrillation in critical care","volume":"8","author":"Nelson","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bja.2021.11.016_bib18","series-title":"Cochrane handbook for\u00a0systematic reviews of interventions, Version 5.1.0","year":"2011"},{"key":"10.1016\/j.bja.2021.11.016_bib19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2021.11.016_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-019-1149-7","article-title":"Protocol for a systematic review and network meta-analysis of the management of new onset atrial fibrillation in critically unwell adult patients","volume":"8","author":"Johnston","year":"2019","journal-title":"Syst Rev"},{"key":"10.1016\/j.bja.2021.11.016_bib21","article-title":"The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000","journal-title":"Ottawa"},{"key":"10.1016\/j.bja.2021.11.016_bib22","first-page":"60","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"Evid Based Med"},{"key":"10.1016\/j.bja.2021.11.016_bib23","first-page":"1","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2021.11.016_bib24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","article-title":"Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial","volume":"8","author":"Kakihana","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.bja.2021.11.016_bib25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/00000542-199811000-00004","article-title":"\u03b2-Adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias","volume":"89","author":"Balser","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2021.11.016_bib26","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/00003246-199511000-00005","article-title":"Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study","volume":"23","author":"Moran","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00134-019-05822-8","article-title":"Prognostic impact of sustained new-onset atrial fibrillation in critically ill patients","volume":"46","author":"Yoshida","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib28","first-page":"94","article-title":"Diltiazem versus amiodarone for new-onset atrial arrhythmias in non-cardiac post surgical patients: a cohort study","volume":"11","author":"Gerlach","year":"2008","journal-title":"Crit Care Shock"},{"key":"10.1016\/j.bja.2021.11.016_bib29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/clc.20268","article-title":"Successful conversion of recent-onset atrial fibrillation by sequential administration of up to three antiarrhythmic drugs","volume":"31","author":"Milicevic","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.bja.2021.11.016_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6136","article-title":"Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients: a clinical framework","volume":"11","author":"Sleeswijk","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.bja.2021.11.016_bib31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1540-8167.2005.40748.x","article-title":"Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment","volume":"16","author":"Hayashi","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.bja.2021.11.016_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.CCM.0000048627.39686.79","article-title":"Effectiveness of direct-current cardioversion for treatment of supraventricular tachyarrhythmias, in particular atrial fibrillation, in surgical intensive care patients","volume":"31","author":"Mayr","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-002-1317-3","article-title":"Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed","volume":"28","author":"Hennersdorf","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0018578719868405","article-title":"Evaluation of amiodarone use for new-onset atrial fibrillation in critically ill patients with septic shock","volume":"56","author":"Betthauser","year":"2021","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.bja.2021.11.016_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcrc.2019.08.026","article-title":"Hemodynamic profiles following digoxin use in patients with sepsis in the ICU","volume":"54","author":"Herasevich","year":"2019","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.bja.2021.11.016_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0310057X18811815","article-title":"High serum potassium level is associated with successful electrical cardioversion for new-onset atrial fibrillation in the intensive care unit: a retrospective observational study","volume":"47","author":"Kyo","year":"2019","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2021.11.016_bib37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jemermed.2018.12.010","article-title":"Esmolol compared with amiodarone in the treatment of recent-onset atrial fibrillation (RAF): an emergency medicine external validity study","volume":"56","author":"Milojevic","year":"2019","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.bja.2021.11.016_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jss.2018.03.009","article-title":"Impact and treatment success of new-onset atrial fibrillation with rapid ventricular rate development in the surgical intensive care unit","volume":"229","author":"Brown","year":"2018","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.bja.2021.11.016_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jcrc.2017.11.040","article-title":"The impact of sustained new-onset atrial fibrillation on mortality and stroke incidence in critically ill patients: a retrospective cohort study","volume":"44","author":"Yoshida","year":"2018","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.bja.2021.11.016_bib40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcrc.2017.04.027","article-title":"Propafenone for supraventricular arrhythmias in septic shock\u2014comparison to amiodarone and metoprolol","volume":"41","author":"Balik","year":"2017","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.bja.2021.11.016_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0885066615599150","article-title":"Prevalence and course of atrial fibrillation in critically ill trauma patients","volume":"32","author":"Duby","year":"2017","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-016-1548-2","article-title":"Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation","volume":"20","author":"Liu","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.bja.2021.11.016_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-016-1252-2","article-title":"Variable use of amiodarone is associated with a greater risk of recurrence of atrial fibrillation in the critically ill","volume":"20","author":"Mitri\u0107","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.bja.2021.11.016_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1378\/chest.15-0959","article-title":"Practice patterns and outcomes of treatments for atrial fibrillation during sepsis","volume":"149","author":"Walkey","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.bja.2021.11.016_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5492\/wjccm.v4.i3.251","article-title":"Landiolol, an ultra-short-acting \u03b21-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis","volume":"4","author":"Okajima","year":"2015","journal-title":"World J Crit Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib46","first-page":"376","article-title":"Analysis of postoperative new-onset atrial fibrillation in critically ill patients undergoing noncardiac surgery","volume":"40","author":"Xie","year":"2015","journal-title":"PLAMJ"},{"key":"10.1016\/j.bja.2021.11.016_bib47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1060028013512473","article-title":"Intravenous metoprolol versus diltiazem for rate control in noncardiac, nonthoracic postoperative atrial fibrillation","volume":"48","author":"Personett","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bja.2021.11.016_bib48","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.jcrc.2011.10.011","article-title":"Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients","volume":"27","author":"Kanji","year":"2012","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.bja.2021.11.016_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00508-004-0297-4","article-title":"Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critically ill patient population","volume":"117","author":"Delle Karth","year":"2005","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.bja.2021.11.016_bib50","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF03040901","article-title":"High-dosage continuous amiodarone therapy to treat new-onset sapraventricular tachyarrhythmias in surgical intensive care patients: an observational study","volume":"116","author":"Mayr","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.bja.2021.11.016_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/clc.4960230408","article-title":"Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide?","volume":"23","author":"Varriale","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.bja.2021.11.016_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031678","article-title":"Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study","volume":"9","author":"Balik","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.bja.2021.11.016_bib53","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1097\/CCM.0b013e3181709e43","article-title":"Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials","volume":"36","author":"Kanji","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bja.2021.11.016_bib54","first-page":"1","article-title":"Managing new-onset atrial fibrillation in critically ill patients: a systematic narrative review","volume":"10","author":"O\u2019Bryan","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.bja.2021.11.016_bib55","article-title":"Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey","volume":"8","author":"Welters","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.bja.2021.11.016_bib56","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1093\/eurheartj\/sux039","article-title":"Landiolol for managing atrial fibrillation in intensive care","volume":"20","author":"Rehberg","year":"2018","journal-title":"Eur Hear J Suppl"},{"key":"10.1016\/j.bja.2021.11.016_bib57","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00134-016-4351-2","article-title":"Heart rate reduction\u00a0with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study","volume":"42","author":"Morelli","year":"2016","journal-title":"Intensive Care Med"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091221007443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091221007443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:02:13Z","timestamp":1757790133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091221007443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0007091221007443"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2021.11.016","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of new onset atrial fibrillation in critically unwell adult patients: a systematic review and narrative synthesis","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2021.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}